Literature DB >> 29479776

Anaplastic variant of diffuse large B-cell lymphoma with hallmark cell appearance: Two cases highlighting a broad diversity in the diagnostics.

Ayako Sakakibara1,2, Kei Kohno1, Naoto Kuroda3, Kenji Yorita3, Nirmeen A Megahed1,4, Ahmed E Eladl1,4, Teerada Daroontum1,5, Eri Ishikawa1, Yuka Suzuki1, Satoko Shimada1, Masato Nakaguro1, Yoshie Shimoyama1, Akira Satou6, Seiichi Kato7, Yasushi Yatabe7, Naoko Asano8, Shigeo Nakamura1.   

Abstract

The anaplastic variant of diffuse large B-cell lymphoma (A-DLBCL) is morphologically defined but remains an enigmatic disease in its clinicopathologic distinctiveness. Here, we report two cases involving Japanese women aged 59 years, both with A-DLBCL with the hallmark cell appearance and both indistinguishable from common and giant cell-rich patterns, respectively, of anaplastic lymphoma kinase (ALK)-positive anaplastic large cell lymphoma. Case 1 was immunohistochemically positive for CD20, CD79a and OCT-2 but not for the other pan-B-cell markers, CD30 and ALK. Case 2 showed CD20 and CD30 positivity for 50% and 20% of tumor cells in addition to strong expression of p53 and MYC. Both were positive for fascin without Epstein-Barr virus association. Our cases provide additional support for the earlier reports that A-DLBCL exhibits clinicopathologic features distinct from ordinal diffuse large B-cell lymphoma (DLBCL), and documented its broader morphologic diversity than previously recognized. They also shed light on the unique feature of absent expression of pan-B-cell markers except for CD20 and CD79a, suggesting that A-DLBCL may biologically mimic a gray zone or intermediate lymphoma between DLBCL and classic Hodgkin lymphoma.
© 2018 Japanese Society of Pathology and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  anaplastic variant; classic Hodgkin lymphoma; diffuse large B-cell lymphoma; gray zone lymphoma; hallmark cell

Mesh:

Substances:

Year:  2018        PMID: 29479776     DOI: 10.1111/pin.12653

Source DB:  PubMed          Journal:  Pathol Int        ISSN: 1320-5463            Impact factor:   2.534


  3 in total

1.  Anaplastic Diffuse Large B Cell Lymphoma: A Single Center Experience.

Authors:  Neha Singh; Ridhi Sood; Narendra Agrawal; Sunil Pasricha; Anurag Mehta
Journal:  Indian J Hematol Blood Transfus       Date:  2019-02-09       Impact factor: 0.900

2.  Primary splenic anaplastic variant of diffuse large B-cell lymphoma: a case report.

Authors:  Sawsan Ismail; Filip Ali; Hussein Ajamieh; Samir Kanaan; Rana Issa; Ali Daoud; Zuheir Alshehabi
Journal:  J Med Case Rep       Date:  2021-05-06

3.  CD30-Positive Anaplastic Variant of Diffuse Large B-cell Lymphoma: Frequency and Association With Clinicopathological Parameters.

Authors:  Atif A Hashmi; Rimsha Haider; Gul Nargus; Omer Ahmed; Syed Rafay Yaqeen; Ishaq Azeem Asghar; Anoshia Afzal; Muhammad Irfan; Muhammad M Edhi; Javaria Ali
Journal:  Cureus       Date:  2021-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.